EDGAR Filing Documents for 0001654954-17-005148

Form S-3 - Registration statement under Securities Act of 1933:

SEC Accession No. 0001654954-17-005148

Filing Date

2017-05-26

Accepted

2017-05-26 16:31:11

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	S-3	v052617_S-3.htm	S-3	393293
2	EXHIBIT 4.6	v052617_ex4-62017.htm	EX-4.6	583261
3	EXHIBIT 5.1	v052617_ex5-12017.htm	EX-5.1	40372
4	EXHIBIT 10.1	v052617_EX10-1.htm	EX-10.1	312940
5	EXHIBIT 12.1	v052617_ex12-1.htm	EX-12.1	11911
6	EXHIBIT 23.1	v052617_ex23-12017.htm	EX-23.1	4057
7	IMAGE	tgtxforms-351737290501v4000.jpg	GRAPHIC	3448
8	IMAGE	tlogo_alston.jpg	GRAPHIC	6846
	Complete submission text file	0001654954-17-005148.txt		1361601

Mailing Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014

Business Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014 (212) 554-4484

TG THERAPEUTICS, INC. (Filer) CIK: 0001001316 (see all company filings)